Streetwise Reports' Article Archives — January 2018 back to current month (60)
Medical Device Firm Boosts Quarterly Revenue 50% YOY (01/31/2018)
A Maxim Group report noted the recently announced revenue achieved and anticipated by this producer of cancer treatment devices.
Jason Kolbert, an analyst with Maxim Group, explained the drivers behind adding this drug and drug delivery developer to his coverage universe.
H.C. Wainwright & Co. reported on the significance of preliminary data for treatments for head and neck cancer, as well as for cervical cancer.
Idaho Gold Projects Benefit from US Fiscal Policy (01/30/2018)
The U.S. dollar index is now at its lowest level since 2014, creating a tailwind for domestic gold producers.
This new exploration company with an experienced team at the helm begins trading on the TSX Venture Exchange on Tuesday.
Is the Shine Coming Back to Silver? (01/29/2018)
Technical analyst Clive Maund sees upside in the charts for silver.
GFG Resources and the Curse of Big Deposits (01/29/2018)
Bob Moriarty of 321 Gold explains why he believes the acquisition of properties in Ontario is a win-win for the explorer and for investors.
Has Gold Bottomed? (01/29/2018)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets.
A multiyear agreement with a German automotive company for residential AC battery systems catapults this company to a new level.
Bullish Signals for Gold (01/28/2018)
Technical analyst Clive Maund charts gold and reports he is finding bullish signals.
A tech company often used by government agencies collaborates with two marquee blockchain partners to create a blockchain network that virtually any government agency or business can use for secure quality and safety audits.
Bob Moriarty of 321 Gold discusses the role of sentiment in the commodities markets and what it means for investors.
Pancreatic Cancer Trial Data Will Be Released Soon (01/24/2018)
A biotech company that has begun clinical testing of human antibodies to treat cancers is in discussion with potential partners.
André Uddin, an analyst with Mackie Research Capital Corp., shared his thesis for investing in this biotech.
With the dollar sliding, technical analyst Clive Maund says the outlook for gold and silver could not be better.
Imagine if you could know if your iPhone was dropped in shipment, if medicine you had ordered had gotten too hot and lost its efficacy, or if a designer bag was authentic or counterfeit. Smart labels developed by this company could make all that possible.
Kevin MacKenzie, an analyst with Canaccord Genuity, explained the rationale for adding this junior exploration company to his coverage universe.
Jack Chan's Weekly Precious Metals Update (01/23/2018)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets.
Ron Struthers of Struthers Resource Stock Report discusses the downfall of cryptocurrencies and the rise of gold, and presents four gold companies he is adding to his selection list.
Gold on the Move (01/22/2018)
Since bottoming on December 11, 2017, at $1,242, gold has tacked on nearly $100 to its price. Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss what they see going on.
Anaconda Sitting on a Gold Mine (01/19/2018)
Bob Moriarty of 321 Gold sees a lot of potential in this company's Nova Scotia and Newfoundland projects.
Echelon Wealth Partners detailed the terms and impact of this cell therapy developer's recent alliance in Asia.
Turnarounds Coming at Three Resource Companies? (01/18/2018)
Adrian Day of Adrian Day Asset Management provides updates on three resource companies with recent developments, one of which he deems a good buy now.
Douglas Loe, an analyst with Echelon Partners, outlined the reasons this biotech deserves Top Pick status.
With sales of Tesla's Model 3 and Chevy's Bolt taking off, Ron Struthers of Struthers Resource Stock Report looks at the effects on the lithium and graphite markets for EV batteries.
Michael Ballanger discusses why he believes the U.S. stock market is defying gravity with a record-breaking nine years without a significant correction.
The Critical Investor profiles a base metal developer with a project in British Columbia that recently signed a major funding agreement with Wheaton Precious Metals.
A junior E&P with prime land in Oklahoma's STACK play uses a land swap to jump-start its drilling in an area that is seeing off-the-charts production as oil prices continue to rise.
'Revenue Build' in 2018 Anticipated for Energy Firm (01/16/2018)
Mackie Research Capital Corp. analyst Nikhil Thadani explained how a recent milestone may signify the start of a revenue growth spurt for this supplier of power electronics for energy storage systems.
One analyst believes 2018 could mark a 'dramatic turnaround' for this biotech company, which is at the forefront of using three-dimensional telomere analysis to personalize medical treatment.
A small-cap miner moving forward on its prospects in Argentina has caught the attention of several industry watchers.
Thoughts on Novo (01/15/2018)
With shares of Novo Resources on a rollercoaster since the summer, Bob Moriarty of 321 Gold discusses the company's latest moves.
Exciting News with More to Come (01/15/2018)
Money manager Adrian Day provides updates for a handful of companies in his portfolio.
Jack Chan's Weekly Precious Metals Update (01/15/2018)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, and says that a falling dollar is supportive for metal prices.
Gold in Bulgaria? Drilling Says 'Yes' (01/11/2018)
It's been full speed ahead for this TSX.V-listed gold explorer in Bulgaria, and the drill bit is showing results.
Stick with Our Fab Four for Continued Outperformance (01/11/2018)
While miners have bounced off their December lows, what is in store for 2018? Fincom Investment Partners profiles a handful of companies it believes have an opportunity to double in 2018.
Euro Pacific Capital reviewed the new estimated resource released by this company for its Peruvian mine.
Optimum Entry Point for Gold and Silver Stocks (01/11/2018)
Technical analyst Clive Maund discusses why he believes a massive new sector bull market is about to begin in gold and silver.
André Uddin, an analyst with Mackie Research Capital Corp., discussed the implications of the latest announcement about this firm's most advanced Alzheimer's drug.
As 2018 begins, John McCamant, editor of Medical Technology Stock Letter, reviews several 2017 top performers, discusses the turnaround at the FDA, and profiles one company with an innovative non-statin LDL cholesterol in the pipeline.
Michael King of JMP Securities provides a comprehensive round-up of companies he has selected for the 2018 Biotech Watchlist—companies in immuno-oncology, gene editing, and other indications that he believes offer promising opportunities for patients and investors.
A company marketing a product designed to enhance women's sexual function announced preliminary financial results for Q4/17 that caught the attention of several analysts.
As zinc continues to rise, The Critical Investor profiles an explorer consolidating claims in southeastern British Columbia.
As this gold explorer continues to test its Australian property, an updated preliminary feasibility study is expected this quarter.
Getting Bullish on Gold (01/08/2018)
Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss gold's recent moves and potential signs of a bull market.
Jack Chan's Weekly Precious Metals Update (01/08/2018)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, noting a falling dollar is supportive for metal prices.
A Top Lithium Pick for a Red-Hot Market (01/08/2018)
With lithium remaining a hot commodity and EV sales expected to grow exponentially, Ron Struthers of Struthers' Resource Stock Report profiles his top lithium stock.
Company Aims to Be Lowest-Cost Blockchain Producer (01/06/2018)
A company that aims to become the lowest-cost producer for digital currency mining and blockchain infrastructure has picked up a facility with low-cost electricity in Washington State.
Analysts Increase Target Prices on Cobalt Pure-Play (01/06/2018)
With electric vehicle demand booming, cobalt is a hot commodity, rising about 130% in 2017. This TSX.V-listed company offers one of the few ways to gain pure-play exposure.
Melt-up, Up, and Away (01/05/2018)
Precious metals expert Michael Ballanger likes what he sees for gold in 2018's first week of trading.
New App Could Push Social Media to a New Level (01/04/2018)
As social media has evolved, it has attracted more and more users. Michael Sheikh of Falcon Strategic Research discusses a company with an app that he believes will break through the constraints of social media.
Gold: Not the Typical Year-End Buying Opportunity (01/04/2018)
Ron Struthers of Struthers' Resource Stock Report takes a look back at gold's performance in the last quarter of 2017, and describes a producer he'll be adding to his portfolio in early 2018.
Miners of the Modern Yukon Gold Rush (01/04/2018)
Ron Struthers of Struthers’ Resource Stock Report describes a miner making a promising stand in the Far North, as well as other Yukon-based gold companies that have captured his attention.
2018: The Year of Living Dangerously (01/03/2018)
What does the New Year hold in terms of prospects for investors in gold, silver and copper? How will central banks and cryptocurrencies play into the health of global financial markets? Precious metals expert Michael Ballanger ponders the possibilities.
Technical analyst Clive Maund charts a gold company that he believes has the potential to make big percentage gains in a short period.
Portfolio Manager's Biotech Watchlist Picks for 2018 (01/02/2018)
StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this interview with The Life Sciences Report, portfolio manager Bruce Campbell highlights four companies that he is putting on Streetwise Reports' 2018 Biotech Watchlist.
Jack Chan's Weekly Precious Metals Market Update (01/02/2018)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, noting buy signals for both gold and silver at the close of 2017.
The Road Ahead for Oil (01/02/2018)
Technical analyst Clive Maund charts oil and suggests that a commodities bull market may be brewing.
A Silver Stock Rated a Strong Buy (01/02/2018)
Clive Maund conducts a technical analysis on a silver company and finds it is at a good entry point.
Expert Calls this Explorer a Buy (01/02/2018)
Adrian Day of Adrian Day Asset Management describes why investors should consider this "well-run gold exploration company with downside protection and plenty of upside."
|"We see GSV as well positioned to be acquired."|
|"EFR does have uranium inventory that could be sold immediately."|
|"We expect PVG, a value-oriented gold name, to outperform."|
|"TRCH is seeing a positive oil/gas result during frack fluid flowback."|
|"GCN looks like it is going to break out imminently."|